Delayed endocrine pancreas graft function after simultaneous pancreas-kidney transplantation. Incidence, risk factors, and impact on long-term outcome

Christoph Troppmann, Angelika C. Gruessner, Basil E. Papalois, David E R Sutherland, Arthur J. Matas, Enrico Benedetti, Rainer W G Gruessner

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background. The incidence of delayed endocrine pancreas graft function and its impact on long-term outcome after simultaneous pancreas-kidney transplantation are unknown. Methods. We studied 54 technically successful adult type I insulin-dependent diabetic recipients of cadaver, whole organ, bladder-drained simultaneous pancreas-kidney transplants (mean age, 37.6 years; 65% male, 35% female; 9% pancreas retransplants; 63% on chronic pretransplant dialysis; mean duration of diabetes, 25.1 years). Insulin was administered during the first 2 weeks after transplantation, as needed, to keep blood glucose <150 mg/dl. Delayed endocrine pancreas graft function was defined as total, cumulative insulin requirement of >30 U between day 5 and day 10, and/or >15 U between day 11 and day 15. Quadruple immunosuppression was used for all recipients. Results. The incidence of delayed endocrine pancreas graft function was 69%. By univariate analysis, delayed endocrine graft function was associated with pretransplant recipient weight >80 kg (P=0.04), donor age >45 years (P=0.02), and cardiocerebrovascular (P=0.06) and nontraumatic causes of donor death (P=0.02). The incidence of acute pancreas rejection episodes was similar for recipients without and with delayed endocrine pancreas graft function. Pancreas graft survival at 1 and 3 years was 94% and 82% without versus 76% and 59% with delayed endocrine graft function (P=0.03). Conclusions. Increased pancreas graft failure after delayed endocrine function was a consequence of insufficient functional reserve (e.g., older donors) rather than increased immunogenicity. Pretransplant reduction of recipient weight and careful donor selection are therefore crucial in order to decrease the incidence of delayed endocrine pancreas graft function and its negative impact on long-term outcome.

Original languageEnglish (US)
Pages (from-to)1323-1330
Number of pages8
JournalTransplantation
Volume61
Issue number9
StatePublished - May 15 1996
Externally publishedYes

Fingerprint

Pancreas Transplantation
Islets of Langerhans
Kidney Transplantation
Pancreas
Transplants
Incidence
Delayed Graft Function
Insulin
Donor Selection
Graft Survival
Cadaver
Immunosuppression
Blood Glucose
Weight Loss
Dialysis
Cause of Death
Urinary Bladder
Transplantation
Kidney
Weights and Measures

ASJC Scopus subject areas

  • Immunology
  • Transplantation

Cite this

Troppmann, C., Gruessner, A. C., Papalois, B. E., Sutherland, D. E. R., Matas, A. J., Benedetti, E., & Gruessner, R. W. G. (1996). Delayed endocrine pancreas graft function after simultaneous pancreas-kidney transplantation. Incidence, risk factors, and impact on long-term outcome. Transplantation, 61(9), 1323-1330.

Delayed endocrine pancreas graft function after simultaneous pancreas-kidney transplantation. Incidence, risk factors, and impact on long-term outcome. / Troppmann, Christoph; Gruessner, Angelika C.; Papalois, Basil E.; Sutherland, David E R; Matas, Arthur J.; Benedetti, Enrico; Gruessner, Rainer W G.

In: Transplantation, Vol. 61, No. 9, 15.05.1996, p. 1323-1330.

Research output: Contribution to journalArticle

Troppmann, C, Gruessner, AC, Papalois, BE, Sutherland, DER, Matas, AJ, Benedetti, E & Gruessner, RWG 1996, 'Delayed endocrine pancreas graft function after simultaneous pancreas-kidney transplantation. Incidence, risk factors, and impact on long-term outcome', Transplantation, vol. 61, no. 9, pp. 1323-1330.
Troppmann, Christoph ; Gruessner, Angelika C. ; Papalois, Basil E. ; Sutherland, David E R ; Matas, Arthur J. ; Benedetti, Enrico ; Gruessner, Rainer W G. / Delayed endocrine pancreas graft function after simultaneous pancreas-kidney transplantation. Incidence, risk factors, and impact on long-term outcome. In: Transplantation. 1996 ; Vol. 61, No. 9. pp. 1323-1330.
@article{ac963366fb8740b8b30ea66fc4c19816,
title = "Delayed endocrine pancreas graft function after simultaneous pancreas-kidney transplantation. Incidence, risk factors, and impact on long-term outcome",
abstract = "Background. The incidence of delayed endocrine pancreas graft function and its impact on long-term outcome after simultaneous pancreas-kidney transplantation are unknown. Methods. We studied 54 technically successful adult type I insulin-dependent diabetic recipients of cadaver, whole organ, bladder-drained simultaneous pancreas-kidney transplants (mean age, 37.6 years; 65{\%} male, 35{\%} female; 9{\%} pancreas retransplants; 63{\%} on chronic pretransplant dialysis; mean duration of diabetes, 25.1 years). Insulin was administered during the first 2 weeks after transplantation, as needed, to keep blood glucose <150 mg/dl. Delayed endocrine pancreas graft function was defined as total, cumulative insulin requirement of >30 U between day 5 and day 10, and/or >15 U between day 11 and day 15. Quadruple immunosuppression was used for all recipients. Results. The incidence of delayed endocrine pancreas graft function was 69{\%}. By univariate analysis, delayed endocrine graft function was associated with pretransplant recipient weight >80 kg (P=0.04), donor age >45 years (P=0.02), and cardiocerebrovascular (P=0.06) and nontraumatic causes of donor death (P=0.02). The incidence of acute pancreas rejection episodes was similar for recipients without and with delayed endocrine pancreas graft function. Pancreas graft survival at 1 and 3 years was 94{\%} and 82{\%} without versus 76{\%} and 59{\%} with delayed endocrine graft function (P=0.03). Conclusions. Increased pancreas graft failure after delayed endocrine function was a consequence of insufficient functional reserve (e.g., older donors) rather than increased immunogenicity. Pretransplant reduction of recipient weight and careful donor selection are therefore crucial in order to decrease the incidence of delayed endocrine pancreas graft function and its negative impact on long-term outcome.",
author = "Christoph Troppmann and Gruessner, {Angelika C.} and Papalois, {Basil E.} and Sutherland, {David E R} and Matas, {Arthur J.} and Enrico Benedetti and Gruessner, {Rainer W G}",
year = "1996",
month = "5",
day = "15",
language = "English (US)",
volume = "61",
pages = "1323--1330",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Delayed endocrine pancreas graft function after simultaneous pancreas-kidney transplantation. Incidence, risk factors, and impact on long-term outcome

AU - Troppmann, Christoph

AU - Gruessner, Angelika C.

AU - Papalois, Basil E.

AU - Sutherland, David E R

AU - Matas, Arthur J.

AU - Benedetti, Enrico

AU - Gruessner, Rainer W G

PY - 1996/5/15

Y1 - 1996/5/15

N2 - Background. The incidence of delayed endocrine pancreas graft function and its impact on long-term outcome after simultaneous pancreas-kidney transplantation are unknown. Methods. We studied 54 technically successful adult type I insulin-dependent diabetic recipients of cadaver, whole organ, bladder-drained simultaneous pancreas-kidney transplants (mean age, 37.6 years; 65% male, 35% female; 9% pancreas retransplants; 63% on chronic pretransplant dialysis; mean duration of diabetes, 25.1 years). Insulin was administered during the first 2 weeks after transplantation, as needed, to keep blood glucose <150 mg/dl. Delayed endocrine pancreas graft function was defined as total, cumulative insulin requirement of >30 U between day 5 and day 10, and/or >15 U between day 11 and day 15. Quadruple immunosuppression was used for all recipients. Results. The incidence of delayed endocrine pancreas graft function was 69%. By univariate analysis, delayed endocrine graft function was associated with pretransplant recipient weight >80 kg (P=0.04), donor age >45 years (P=0.02), and cardiocerebrovascular (P=0.06) and nontraumatic causes of donor death (P=0.02). The incidence of acute pancreas rejection episodes was similar for recipients without and with delayed endocrine pancreas graft function. Pancreas graft survival at 1 and 3 years was 94% and 82% without versus 76% and 59% with delayed endocrine graft function (P=0.03). Conclusions. Increased pancreas graft failure after delayed endocrine function was a consequence of insufficient functional reserve (e.g., older donors) rather than increased immunogenicity. Pretransplant reduction of recipient weight and careful donor selection are therefore crucial in order to decrease the incidence of delayed endocrine pancreas graft function and its negative impact on long-term outcome.

AB - Background. The incidence of delayed endocrine pancreas graft function and its impact on long-term outcome after simultaneous pancreas-kidney transplantation are unknown. Methods. We studied 54 technically successful adult type I insulin-dependent diabetic recipients of cadaver, whole organ, bladder-drained simultaneous pancreas-kidney transplants (mean age, 37.6 years; 65% male, 35% female; 9% pancreas retransplants; 63% on chronic pretransplant dialysis; mean duration of diabetes, 25.1 years). Insulin was administered during the first 2 weeks after transplantation, as needed, to keep blood glucose <150 mg/dl. Delayed endocrine pancreas graft function was defined as total, cumulative insulin requirement of >30 U between day 5 and day 10, and/or >15 U between day 11 and day 15. Quadruple immunosuppression was used for all recipients. Results. The incidence of delayed endocrine pancreas graft function was 69%. By univariate analysis, delayed endocrine graft function was associated with pretransplant recipient weight >80 kg (P=0.04), donor age >45 years (P=0.02), and cardiocerebrovascular (P=0.06) and nontraumatic causes of donor death (P=0.02). The incidence of acute pancreas rejection episodes was similar for recipients without and with delayed endocrine pancreas graft function. Pancreas graft survival at 1 and 3 years was 94% and 82% without versus 76% and 59% with delayed endocrine graft function (P=0.03). Conclusions. Increased pancreas graft failure after delayed endocrine function was a consequence of insufficient functional reserve (e.g., older donors) rather than increased immunogenicity. Pretransplant reduction of recipient weight and careful donor selection are therefore crucial in order to decrease the incidence of delayed endocrine pancreas graft function and its negative impact on long-term outcome.

UR - http://www.scopus.com/inward/record.url?scp=0029876841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029876841&partnerID=8YFLogxK

M3 - Article

C2 - 8629291

AN - SCOPUS:0029876841

VL - 61

SP - 1323

EP - 1330

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 9

ER -